Company

ITM Medical Isotopes

As of the edition of 20 October 2026, ITM Medical Isotopes runs 1 drug; it is on route A at 6 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Withdrawn from market1
Total1

Where it needs a new molecule

Route A at 6 targets, route B at 0 targets.

Three of its 6 rows, by target and route
TargetRoute
SSTR5 Somatostatin receptor type 5Route A
SSTR3 Somatostatin receptor type 3Route A
SSTR1 Somatostatin receptor type 1Route A

All 6 rows on route A or B

In the product

6 company-target rows on route A or B; 3 are not shown here, and no score is.